Patents by Inventor Alexander Mark Schobel

Alexander Mark Schobel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240050317
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Application
    Filed: October 18, 2023
    Publication date: February 15, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell
  • Publication number: 20240016734
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described and the compositions having enhanced active component permeation properties are described as being administered with specific residence times.
    Type: Application
    Filed: June 14, 2023
    Publication date: January 18, 2024
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Publication number: 20230414452
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Application
    Filed: September 7, 2023
    Publication date: December 28, 2023
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell
  • Patent number: 11806311
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: November 7, 2023
    Assignee: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell
  • Publication number: 20230149304
    Abstract: An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
    Type: Application
    Filed: November 17, 2022
    Publication date: May 18, 2023
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee
  • Publication number: 20230145752
    Abstract: An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
    Type: Application
    Filed: December 30, 2022
    Publication date: May 11, 2023
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee
  • Publication number: 20230138361
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: June 8, 2022
    Publication date: May 4, 2023
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Publication number: 20230131450
    Abstract: A method of administering diazepam having a food effect is described.
    Type: Application
    Filed: October 25, 2022
    Publication date: April 27, 2023
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Stephen Paul Wargacki, Alexander Mark Schobel
  • Publication number: 20230130055
    Abstract: Soluble drug delivery films can exhibit an enhanced stability.
    Type: Application
    Filed: October 21, 2022
    Publication date: April 27, 2023
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Stephen Paul Wargacki, Rajesh Kumar Kainthan, Vincent Buono, Alexander Mark Schobel, Michael Koons, Michael Goodrich, Gregory Tsodikov
  • Patent number: 11541002
    Abstract: An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: January 3, 2023
    Assignee: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee
  • Publication number: 20220347117
    Abstract: Self-supporting film unit dosage forms for oral transmucosal delivery are disclosed herein containing an active. These film dosage forms for oral transmucosal delivery have a substantially equivalent pharmacokinetic profile to dosage forms administered by another route or in another dosage form (e.g., tablet, patch) and yet have a different amount of active contained therein.
    Type: Application
    Filed: March 9, 2022
    Publication date: November 3, 2022
    Inventors: Alexander Mark Schobel, Stephen Wargacki
  • Publication number: 20220233471
    Abstract: Systems and methods of delivering a drug product by inhalation can include a prodrug composition.
    Type: Application
    Filed: January 15, 2022
    Publication date: July 28, 2022
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark SCHOBEL, Daniel R. BARBER, Stephen Paul WARGACKI, Rajesh Kumar KAINTHAN, Stephanie M. VARJAN, Malarvizhi DURAI
  • Publication number: 20220160657
    Abstract: Pharmaceutical compositions of epinephrine and its prodrugs are described, the prodrugs having a half-life of less than one minute, and the compositions having enhanced active component permeation properties are described.
    Type: Application
    Filed: December 13, 2021
    Publication date: May 26, 2022
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Patent number: 11273131
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: March 15, 2022
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Patent number: 11191737
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: December 7, 2021
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Patent number: 11160771
    Abstract: Pharmaceutical compositions having enhanced active component permeation properties are described.
    Type: Grant
    Filed: May 4, 2017
    Date of Patent: November 2, 2021
    Assignee: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie Marie Varjan, Stephen Paul Wargacki
  • Publication number: 20210145731
    Abstract: A method of administering diazepam with a multimodal delivery profile is described.
    Type: Application
    Filed: November 14, 2020
    Publication date: May 20, 2021
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephanie M. Varjan, Stephen Paul WARGACKI, Gary SLATKO, Allen H. Heller
  • Publication number: 20210128511
    Abstract: Pharmaceutical compositions include a prodrug of epinephrine are described.
    Type: Application
    Filed: November 1, 2020
    Publication date: May 6, 2021
    Applicant: AQUESTIVE THERAPEUTICS, INC.
    Inventors: Alexander Mark Schobel, Stephen Paul Wargacki, Stephanie M. VARJAN, Rajesh Kumar Kainthan, Malarvizhi Durai
  • Publication number: 20200101009
    Abstract: An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
    Type: Application
    Filed: September 5, 2019
    Publication date: April 2, 2020
    Inventors: Alexander Mark Schobel, Stephen Wargacki, Vincent J. Buono, Susan Shumard, Christopher James Santee
  • Publication number: 20190388302
    Abstract: Systems and methods for making and delivering personalized, medically prescribed pharmaceuticals to an individual patient are described. Individual unit doses (IUDs) of medicine may be prepared specific to the individual in need of same, by using a system, which includes a networked control system in combination with manufacturing assemblies specific to the IUDs and delivering the medicine to the patient directly from the manufacturer.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 26, 2019
    Applicant: Aquestive Therapeutics, Inc.
    Inventors: Alexander Mark Schobel, Keith Kendall, Dan Barber, Theresa Wood, Peter Boyd, John Maxwell